![Judith Klimovsky](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Judith Klimovsky
Directeur/Membre du Conseil chez
BIO-TECHNE CORPORATION
Fortune : 195 454 $ au 31/05/2026
Profil
Judith Klimovsky currently works at Bio-Techne Corp., as Independent Director from 2024 and Genmab A, as Chief Development Officer & Executive VP from 2017.
Dr. Klimovsky also formerly worked at Bellicum Pharmaceuticals, Inc., as Director from 2018 to 2024, Novartis AG, as Senior Vice President & Head-Clinical Development from 2015 to 2017, and Novartis Pharma AG, as Senior Vice President & Head-Clinical Development from 2009 to 2017.
Dr. Klimovsky received her doctorate degree from the University of Buenos Aires School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/10/2025 | 3 782 ( 0% ) | 195 454 $ | 31/05/2026 |
Postes actifs de Judith Klimovsky
| Sociétés | Poste | Début |
|---|---|---|
| GENMAB A/S | Corporate Officer/Principal | 09/02/2017 |
| BIO-TECHNE CORPORATION | Directeur/Membre du Conseil | 24/04/2024 |
Anciens postes connus de Judith Klimovsky
| Sociétés | Poste | Fin |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 23/02/2024 |
| NOVARTIS AG | Corporate Officer/Principal | 01/02/2017 |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Corporate Officer/Principal | 01/01/2017 |
Formation de Judith Klimovsky
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
61
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Bio-Techne Corp.
 Bio-Techne Corp. BiotechnologyHealth Technology Manufactures and sells biological products | Health Technology |
Bellicum Pharmaceuticals, Inc.
 Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Genmab A/S
 Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
University of Buenos Aires School of Medicine
 University of Buenos Aires School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
